Chris Murphy actually said...

"I think we have learned a lot of lessons over the past decade about the difference between unilateral action and multilateral action."

"According to probably the most comprehensive FDA study that we have, the leading cause of these drug shortages are quality problems during manufacturing."

"None of the reasons that the FDA cites are due to pricing issues, and certainly none of them are related to 340(b)."

"We could have been having a conversation about how we specifically take on the issue of forced abortion in China."